Podravka stock: Food and pharmaceuticals support 2026 growth

Published on 11/12/2026 at 01:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Podravka stock gains a fresh earnings focus after the group reported higher revenue for the first nine months of 2026. Food and pharma led growth.

Growth led by food and pharmaceuticals

Podravka Group maintained revenue growth and high normalised profitability in the first nine months of 2026.
Food and pharmaceuticals offset weaker agriculture, where lower commodity prices and drought pressured results.

Podravka, HRPODRRA0004, Illustration mit AI erstellt.

Podravka Group reported higher operating revenue and normalised profitability for the first nine months of 2026, according to the company's October 29 earnings release. The Croatian group said food and pharmaceuticals were the main contributors, while agriculture faced weaker market conditions.

Core segments drive performance

Operating revenue reached EUR 787.7 million from January through September, up EUR 5.5 million from the comparable period. Normalised EBITDA was EUR 129.9 million and normalised net profit was EUR 57.6 million.

Food revenue amounted to EUR 449.1 million, with own-brand sales rising 1.5% to EUR 408.1 million. Podravka highlighted bakery products, cream spreads and confectionery, with Lino Lada showing strong growth in Germany, Poland and the Czech Republic.

Pharmaceutical growth offsets agriculture

Pharmaceuticals generated EUR 140.8 million in revenue, an 8.8% increase from a year earlier. Over-the-counter products were a particular growth driver, with revenue rising 19.2% to EUR 22.5 million.

Agriculture revenue declined 1.8% to EUR 204.3 million. Lower prices for pigs, fattening cattle and raw milk, together with drought-related crop losses, weighed on the segment, although operational improvements helped limit the impact.

Regional food and healthcare group

Podravka is headquartered in Koprivnica, Croatia, and operates across food, agriculture and pharmaceuticals. The group has more than 8,400 employees, a portfolio of more than 1,900 products and operations in more than 60 markets. Its brands include Vegeta, Lino, Dolcela, Fant, ?okolino, Kviki, Neofen and Belje, positioning Podravka as a diversified food, agriculture and pharmaceutical company in Southeast and Central Europe.